Replicel Life Sciences Inc V.RP

It's Time

[Ingiboy]

Now the AGM has come and gone I think Replicel will begin to roll out the game plan for 2021.
The deal with Mainpointe should be completed in the next week or so and submitted for TSXV  approval.  Once this is done the money should begin to flow into Replicel.  It sounds like it has taken a bit longer for these preliminary steps than first announced (Nov. 11th NR).
Once the money is in place I assume we will hear a more detailed description of how the Dermal injector will be tested and subsequently the FDA application.
We should then see some larger investors especially in the U.S. who have been waiting to see if this device is the real deal.  Presently all we are seeing is daytrading which will take the share price nowhere.  We need some large volume to push through this daytrading wall.

[sammie88]

Based on previous trends, I don't think the completion of the Mainpointe deal itself will start the upwards movement. Everyone already knows that it'll be completed within the next few weeks, but the market hasnt responded yet. I don't know if it will change even after Replicel announces its completion. Once they announce FDA, or CE approval, then we're talking $$. Im very

[MetzGER]

„We've been waiting patiently for a while.“ Not Always :D

[Genie29j]

I think this makes sense as well. The real needle movers will be 1. FDA /CE MARK approval 2. positive results on ANY of the RCH products 3. Positive news from Shiseido  4. The start to license RCI I think multiple of these could come to fruition in 2021